SCOLIOSIS SOS LIMITEDActive
Key figures
Like most small UK companies, SCOLIOSIS SOS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £150,000.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 309,661 | 302,960 | 332,958 | 256,861 | 411,432 |
| Total assets | — | — | — | — | — |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 5,028,727 | 5,488,761 | 5,707,586 | 5,890,880 | 6,753,625 |
| Average number of employees | 28 | 27 | 26 | 27 | 22 |
| Dividends paid | — | — | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company during the financial year was the provision of intensive rehabilitation treatment and equipment.
As described in the company's latest filed accounts.
Summary: SCOLIOSIS SOS LIMITED
Company
SCOLIOSIS SOS LIMITED is a private limited company registered with Companies House under company number 05464465. It was incorporated on 26 May 2005. Its status is active. The registered office is in London (E1). Its nature of business (SIC 2007) is specialists medical practice activities (86220).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £6,753,625, up 14.6% on the previous year. Cash at bank and in hand was £411,432. The company had an average of 22 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered. 2 of 4 registered charges are outstanding.
Filing deadlines
The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 1 Oct 2026.